Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2009

01-11-2009 | Original Article

Factors Contributing to Hospitalization for Gastroparesis Exacerbations

Authors: Sesha S. Uppalapati, Zeeshan Ramzan, Robert S. Fisher, Henry P. Parkman

Published in: Digestive Diseases and Sciences | Issue 11/2009

Login to get access

Abstract

Background

The clinical course of patients with gastroparesis is characterized by symptomatic exacerbations often necessitating hospitalization.

Aims

To investigate precipitating factors leading to hospitalization for exacerbation of symptoms in patients with gastroparesis.

Methods

This was a retrospective review of 103 admissions (63 patients) for gastroparesis exacerbation.

Results

Etiologic categories for gastroparetic patients were diabetic (43%), idiopathic (39%), and post surgical (8%). Poor glycemic control was present in 36%, infection in 19% (12 urinary tract infections and two bacteremia), and noncompliance with or intolerance of, medications in six and 5% of patients, respectively. Fasting morning cortisol concentrations were <3 mcg/dl in 9%. Elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were seen in 34 of 65 (52%) and 11 of 50 patients (22%), respectively. No identifiable infection was found in 74 and 45% of patients with elevated ESR and elevated CRP, respectively. ESR and CRP were higher when patients were symptomatic necessitating hospitalization (26.2 ± 6.6 mm/h and 1.6 ± 1.0 mg/l) compared with when they were seen in outpatient follow-up and less symptomatic (10.3 ± 2.9 mm/h and 0.3 ± 0.1 mg/l; P = 0.0001 and P = 0.211, respectively).

Conclusions

Poor glycemic control, infection, noncompliance with/intolerance of medications, and, perhaps, adrenal insufficiency were contributory factors leading to hospitalizations of gastroparetic patients. Hospitalized patients with gastroparesis exacerbations had elevated ESR and CRP levels. Although many patients with elevated inflammatory markers had evidence of infection, some did not. Assessment of inflammatory markers may help indicate those gastroparetic patients in whom a search for infection should be undertaken.
Literature
1.
go back to reference Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589–1591.CrossRefPubMed Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589–1591.CrossRefPubMed
2.
3.
go back to reference Horowitz M, O’Donovan D, Jones KL, et al. Gastric emptying in diabetes clinical significance and treatment. Diabet Med. 2002;19:177–194.CrossRefPubMed Horowitz M, O’Donovan D, Jones KL, et al. Gastric emptying in diabetes clinical significance and treatment. Diabet Med. 2002;19:177–194.CrossRefPubMed
4.
go back to reference Koch K. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus—a review of symptoms, pathophysiology, and treatment. Dig Dis Sci. 1999;44(6):1061–1075.CrossRefPubMed Koch K. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus—a review of symptoms, pathophysiology, and treatment. Dig Dis Sci. 1999;44(6):1061–1075.CrossRefPubMed
5.
go back to reference Wang WR, Fisher RS, Parkman HP. Gastroparesis related hospitalizations in the United States: trends, characteristics and outcomes, 1995–2004. Am J Gastroenterol. 2008;103(2):313–322.CrossRefPubMed Wang WR, Fisher RS, Parkman HP. Gastroparesis related hospitalizations in the United States: trends, characteristics and outcomes, 1995–2004. Am J Gastroenterol. 2008;103(2):313–322.CrossRefPubMed
6.
go back to reference Harberson J, Thomas R, Harbison S, Meilahn J, Parkman HP. Pathology of gastroparesis: assessment of the myenteric plexus and interstitial cells of Cajal. Neurogastroenterol Motil. 2007;19(5):427. (abstract). Harberson J, Thomas R, Harbison S, Meilahn J, Parkman HP. Pathology of gastroparesis: assessment of the myenteric plexus and interstitial cells of Cajal. Neurogastroenterol Motil. 2007;19(5):427. (abstract).
7.
go back to reference Martin ST, Collins CG, Fitzgibbon J, et al. Gastric motor dysfunction: is eosinophilic mural gastritis a causative factor? Eur J Gastroenterol Hepatol. 2005;17(9):983–986.CrossRefPubMed Martin ST, Collins CG, Fitzgibbon J, et al. Gastric motor dysfunction: is eosinophilic mural gastritis a causative factor? Eur J Gastroenterol Hepatol. 2005;17(9):983–986.CrossRefPubMed
8.
go back to reference De Giorgio R, Barbara G, Stanghellini V, et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol. 2000;12(6):613–616.CrossRefPubMed De Giorgio R, Barbara G, Stanghellini V, et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol. 2000;12(6):613–616.CrossRefPubMed
9.
go back to reference Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18(4):641–661.CrossRefPubMed Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18(4):641–661.CrossRefPubMed
10.
go back to reference Pande H, Lacy B, Crowell M. Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci. 2002;47(12):2664–2668.CrossRefPubMed Pande H, Lacy B, Crowell M. Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci. 2002;47(12):2664–2668.CrossRefPubMed
11.
go back to reference American Diabetes Association. Executive summary: standards of medical care in diabetes-2008. Diabetes Care. 2008;31(1):S5–S11.CrossRef American Diabetes Association. Executive summary: standards of medical care in diabetes-2008. Diabetes Care. 2008;31(1):S5–S11.CrossRef
12.
go back to reference Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology. 1988;94:739–744.PubMed Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology. 1988;94:739–744.PubMed
14.
go back to reference Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:675–680.CrossRefPubMed Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:675–680.CrossRefPubMed
15.
go back to reference Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97:604–611.CrossRefPubMed Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97:604–611.CrossRefPubMed
16.
go back to reference Pfutzner A, Forst T. High sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther. 2006;8(1):28–36.CrossRefPubMed Pfutzner A, Forst T. High sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther. 2006;8(1):28–36.CrossRefPubMed
17.
go back to reference Osei-Bimpong A, Meek JH, Lewis SM. ESR or CRP? A comparison of their clinical utility. Hematology. 2007;12(4):353–357.CrossRefPubMed Osei-Bimpong A, Meek JH, Lewis SM. ESR or CRP? A comparison of their clinical utility. Hematology. 2007;12(4):353–357.CrossRefPubMed
18.
go back to reference Shilipak MG, Ix JH, et al. Biomarkers to predict recurrent cardiovascular disease: the heart and soul study. Am J Med. 2008;121(1):50–57.CrossRef Shilipak MG, Ix JH, et al. Biomarkers to predict recurrent cardiovascular disease: the heart and soul study. Am J Med. 2008;121(1):50–57.CrossRef
19.
go back to reference Poole CD, Conway P, Currie CJ. An evaluation of the association between systemic inflammation-as measured by C-reactive protein—and hospital resource use. Curr Med Res Opin. 2007;23(11):2785–2792.CrossRefPubMed Poole CD, Conway P, Currie CJ. An evaluation of the association between systemic inflammation-as measured by C-reactive protein—and hospital resource use. Curr Med Res Opin. 2007;23(11):2785–2792.CrossRefPubMed
20.
21.
go back to reference Grinspoon SK, Biller BMK. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 1994;79:923–931.CrossRefPubMed Grinspoon SK, Biller BMK. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 1994;79:923–931.CrossRefPubMed
Metadata
Title
Factors Contributing to Hospitalization for Gastroparesis Exacerbations
Authors
Sesha S. Uppalapati
Zeeshan Ramzan
Robert S. Fisher
Henry P. Parkman
Publication date
01-11-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0975-1

Other articles of this Issue 11/2009

Digestive Diseases and Sciences 11/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.